Publication Date:
2009-01-06
Description:
Metastatic progression depends on genetic alterations intrinsic to cancer cells as well as the inflammatory microenvironment of advanced tumours. To understand how cancer cells affect the inflammatory microenvironment, we conducted a biochemical screen for macrophage-activating factors secreted by metastatic carcinomas. Here we show that, among the cell lines screened, Lewis lung carcinoma (LLC) were the most potent macrophage activators leading to production of interleukin-6 (IL-6) and tumour-necrosis factor-alpha (TNF-alpha) through activation of the Toll-like receptor (TLR) family members TLR2 and TLR6. Both TNF-alpha and TLR2 were found to be required for LLC metastasis. Biochemical purification of LLC-conditioned medium (LCM) led to identification of the extracellular matrix proteoglycan versican, which is upregulated in many human tumours including lung cancer, as a macrophage activator that acts through TLR2 and its co-receptors TLR6 and CD14. By activating TLR2:TLR6 complexes and inducing TNF-alpha secretion by myeloid cells, versican strongly enhances LLC metastatic growth. These results explain how advanced cancer cells usurp components of the host innate immune system, including bone-marrow-derived myeloid progenitors, to generate an inflammatory microenvironment hospitable for metastatic growth.〈br /〉〈br /〉〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746432/" target="_blank"〉〈img src="https://static.pubmed.gov/portal/portal3rc.fcgi/4089621/img/3977009" border="0"〉〈/a〉 〈a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2746432/" target="_blank"〉This paper as free author manuscript - peer-reviewed and accepted for publication〈/a〉〈br /〉〈br /〉〈span class="detail_caption"〉Notes: 〈/span〉Kim, Sunhwa -- Takahashi, Hiroyuki -- Lin, Wan-Wan -- Descargues, Pascal -- Grivennikov, Sergei -- Kim, Youngjun -- Luo, Jun-Li -- Karin, Michael -- R01 CA118165/CA/NCI NIH HHS/ -- R01 CA118165-02/CA/NCI NIH HHS/ -- R01 CA132586/CA/NCI NIH HHS/ -- R01 ES006376/ES/NIEHS NIH HHS/ -- R01 ES006376-14/ES/NIEHS NIH HHS/ -- T32 CA121938/CA/NCI NIH HHS/ -- England -- Nature. 2009 Jan 1;457(7225):102-6. doi: 10.1038/nature07623.〈br /〉〈span class="detail_caption"〉Author address: 〈/span〉Department of Pharmacology and Cancer Center, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093-0723, USA.〈br /〉〈span class="detail_caption"〉Record origin:〈/span〉 〈a href="http://www.ncbi.nlm.nih.gov/pubmed/19122641" target="_blank"〉PubMed〈/a〉
Keywords:
Animals
;
Antigens, CD14/metabolism
;
Carcinoma, Lewis Lung/*metabolism/pathology/secretion
;
Culture Media, Conditioned/metabolism/pharmacology
;
Culture Media, Serum-Free/metabolism
;
Interleukin-6/metabolism/secretion
;
Liver Neoplasms/secondary
;
Lung Neoplasms/metabolism/pathology/secondary
;
*Macrophage Activation
;
Macrophages/*metabolism/secretion
;
Mice
;
Mice, Inbred C57BL
;
*Neoplasm Metastasis/pathology
;
Neoplasm Transplantation
;
Toll-Like Receptor 2/agonists/*metabolism
;
Toll-Like Receptor 6/metabolism
;
Tumor Necrosis Factor-alpha/metabolism/secretion
;
Versicans/metabolism/pharmacology
Print ISSN:
0028-0836
Electronic ISSN:
1476-4687
Topics:
Biology
,
Chemistry and Pharmacology
,
Medicine
,
Natural Sciences in General
,
Physics
Permalink